New England Surgical Society (NESS)
Search NESS
  Home
  Annual Meeting
  Annual Resident and Fellow Research Day
  Members
      Member Directory
      Members Only
  Scholars Foundation
  Job Board
  Awards
  Journal of the American College of Surgeons
  Newsletters
  Committees
  Contact NESS

90th Annual Meeting Abstracts


Early Stage Primary Gall Bladder Cancer in The Surveillance Epidemiology and End Results (SEER) Database: The Impact of Extent of Surgical Resection.
*Stephanie R Downing, MD1,2, *Tolulope A. Oyetunji, MD, MPH1, *Kerry-Ann Cadogan1, *Gezzer Ortega1, *Suryanarayana M. Siram, MD1, *David C. Chang, PhD, MPH1,2, LaSalle D. Leffall, MD1, Wayne A.I. Frederick, MD1
1Howard University College of Medicine, Washington, DC;2Johns Hopkins University College of Medicine, Baltimore, MD

Objective: To determine the epidemiology and impact of surgery on survival in early stage primary gall-bladder cancer (GBC).
Design: Retrospective analysis of Surveillance Epidemiology and End Results database.
Setting: N/A.
Patients: Potentially surgically curable GBC patients (stages Tis, T1, T2) who underwent a surgical procedure.
Interventions/Comparison: (1) Simple cholecystectomy versus extended surgical resection (ESR), and (2) number of lymph nodes (LN) resected.
Outcome: Survival.
Results: We identified 3209 cases, (58.2% T2, 30.1% T1, 11.7% Tis). Median age at diagnosis was 73 years and 74.8% were female. Median survival was 26 months (Tis, 140 months; T1a, 91 months; T1b, 32 months; T2, 15 months). On multivariate analysis, decreased survival was seen amongst patients aged >60 (HR=1.57, 95%CI=1.30-1.90, p<0.001), increased stage (T1-HR=1.99, 95%CI=1.46-2.70, p<0.001; T2-HR=3.29, 95%CI=2.45-4.43, p<0.001), and LN positivity (regional-HR=1.65, 95%CI=1.39-1.95, p<0.001, distant-HR=2.58, 95%CI=1.54-4.34, p<0.001); while improved survival was found for female patients (HR=0.82, 95%CI=0.70-0.96, p=0.02) and those undergoing ESR (HR=0.59, 95%CI=0.45-0.78, p<0.001). The survival advantage of ESR was seen only in patients with T2 lesions (HR=0.49, 95%CI=0.35-0.68, p<0.001), while there was no survival benefit for ESR in patients with Tis, T1a, or T1b lesions. A subset of 2507 patients had LN excision data, 68.2% having no LN removed, 28.2% 1-4 LN excised and 3.6% 5+ LN excised. On multivariate analysis, patients with 1-4 LN removed had an improved survival over those without LN excision (HR=0.55, 95%CI=0.46-0.66, p<0.001) and those patients with 5+ LN excised had a survival benefit over patients with 1-4 LN removed (HR=0.63, 95%CI=0.40-0.96, p=0.03). Patients with T2 lesions benefited from LN resection (HR=0.42, 95%CI=0.33-0.53, p<0.001).
Conclusion: ESR and/or LN resection may provide a survival benefit in incidentally discovered GBC for certain patients.


 

Copyright © 2018 New England Surgical Society. All Rights Reserved.
Read Privacy Policy.